Tech Company Financing Transactions
Tensha Therapeutics Funding Round
Tensha Therapeutics secured a $15 million Series A funding round on 9/13/2011. Investors included HealthCare Ventures.
Transaction Overview
Company Name
Announced On
9/13/2011
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors
HealthCare Ventures (Douglas Onsi)
Proceeds Purpose
The company's lead program, presently in preclinical development, is a first-in-class small molecule aimed at the treatment of BRD4-NUT midline carcinoma (a rare, invariably fatal cancer), acute myeloid leukemias, multiple myeloma, and other malignancies.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
55 Cambridge Parkway 102
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Not Recorded
Overview
Tensha Therapeutics is developing small molecule bromodomain inhibitors, a new class of epigenetic modulators of gene expression, to treat cancer and other serious disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
James Bradner
Browse more venture capital transactions:
Prev: 9/13/2011: Jildy venture capital transaction
Next: 9/13/2011: TelaDoc venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs